SSII - NASDAQ
SS Innovations International, Inc.
$4.26
+6.2%SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
At a Glance
Live SnapshotSS Innovations International, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
SS Innovations International, Inc. Cash Flow Statement
SSII • NASDAQ
| SS Innovations International, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||
-12.1M | -19.2M | -20.9M | -3.2M | -1.5M | -1.1M | -3.4M | -960.3K | -1M | -485K | |
1.1M | 436K | 152.7K | 96.6K | 18.8K | 37.4K | 37.7K | 19.5K | 789.0 | 0.0 | |
-512.9K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
8.1M | 14.3M | 9.7M | 0.0 | 767.2K | 434.2K | 0.0 | 0.0 | 0.0 | 0.0 | |
687.3K | 950.6K | 5.3M | 285.9K | 1.2M | 20.7K | 2.3M | -283.3K | 218.1K | -17.3K | |
-15.8M | -6.1M | -9.7M | -3.2M | -849.6K | 541.8K | 374.4K | 310.5K | 324.2K | 166.7K | |
-18.5M | -9.5M | -15.4M | -6M | -363K | -90.5K | -424.1K | -443.3K | -446.9K | -190.2K | |
INVESTING ACTIVITIES | ||||||||||
-3.7M | -661.5K | -453.3K | (0.0) | (0.0) | -4K | -50.1K | -23.6K | -4.2K | -43.5K | |
(0.0) | (0.0) | (0.0) | (240.8K) | (38.2K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -40K | (0.0) | (0.0) | (0.0) | (0.0) | |
-3.7M | -661.5K | -453.3K | (240.8K) | (38.2K) | -44K | -50.1K | -23.6K | -4.2K | -43.5K | |
FINANCING ACTIVITIES | ||||||||||
0.0 | 0.0 | 412.1K | 0.0 | 557.1K | 194.8K | 0.0 | 20K | 677.3K | 1.9K | |
26.2M | 9.4M | 22.3M | 5.9M | 0.0 | 69.8K | 427.5K | 30K | -21.9K | 480K | |
(0.0) | (0.0) | (0.0) | (0.0) | -26K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | 50K | 0.0 | 12.9K | 2.1K | 39.5K | 0.0 | 0.0 | 0.0 | |
26.2M | 9.4M | 22.8M | 5.9M | 569.9K | 266.8K | 467K | 50K | 655.4K | 481.9K | |
CASH FLOW SUMMARY | ||||||||||
-985K | 274.2K | -168.1K | -273.7K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
3M | -464.3K | 6.8M | -131.1K | 245.1K | 132.2K | -7.2K | -416.9K | 204.4K | 248.1K | |
6.6M | 7.1M | 274.6K | 405.8K | 160.7K | 28.5K | 35.7K | 452.6K | 248.2K | 100.0 | |
9.6M | 6.6M | 7.1M | 274.6K | 405.8K | 160.7K | 28.5K | 35.7K | 452.6K | 248.2K | |
-22.2M | -10.2M | -15.8M | -1.4M | -363K | -94.5K | -474.2K | -466.9K | -451K | -233.8K |
SEC Filings
SSII - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 26, 2026 | May 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 13, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
S-3 S-3 N/A | May 01, 2026 | May 01, 2026 | ||
8-K 8-K 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 07, 2026 | April 07, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | March 31, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 |
Related Guides
Continue your SSII research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.